Molecular studies are ongoing in regards to superficial urothelial carcinoma of the bladder (UCB) either to define targeted therapy or to better select aggressive therapy candidates and also to delineate the outcome of the disease. In this study, we aimed to present the impact of ALDH1 and CD44 as stem cell markers in tumorigenesis and their prognostic value in urothelial carcinoma. We investigated ALDH1 and CD44 immunohistochemically in paraffin-embedded material of 125 non-muscle-invasive (NMI) cases in 163 UCB patients. In the NMI-UCB subgroup, we found ALDH1 to be significantly correlated with all poor prognostic factors, including high stage (≥pT2), high grade, recurrence and progression development and poor survey (P=0.001) in contrast to CD44 expression (P>0.05). Although ALDH1 expression had a good correlation with a poor clinical course of UCB, it could be used as a molecular marker to determine the best treatment strategy and could contribute to the development of targeted therapies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443164 | PMC |
Publication Analysis
Top Keywords
Similar Publications
DLK1 Is Associated with Stemness Phenotype in Medullary Thyroid Carcinoma Cell Lines.
Int J Mol Sci
November 2024
Genetic Bases of Thyroid Tumour Laboratory, Division of Genetics, Department of Morphology and Genetics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04039-032, SP, Brazil.
Medullary thyroid carcinoma (MTC) is a rare and aggressive tumor, often requiring systemic treatment in advanced or metastatic stages, where drug resistance presents a significant challenge. Given the role of cancer stem cells (CSCs) in cancer recurrence and drug resistance, we aimed to identify CSC subpopulations within two MTC cell lines harboring pathogenic variants in the two most common MEN2-associated codons. We analyzed 15 stemness-associated markers, along with well-established thyroid stem cell markers (CD133, CD44, and ALDH1), a novel candidate (DLK1), and multidrug resistance proteins (MRP1 and MRP3).
View Article and Find Full Text PDFExpression of cancer stem cell markers (CD24, CD44 & ALDH1A3 isoform) in Breast Cancer in Indian population considering clinicopathological characteristics and response to neoadjuvant chemotherapy - a prospective analysis from a university hospital.
Indian J Surg Oncol
December 2024
Department of Surgery (General), King George's Medical University, Lucknow, UP India.
Article Synopsis
- Cancer stem cells (CSCs), marked by CD24 and CD44, are linked to aggressive behavior and poor outcomes in breast cancer, with a study examining 75 tissue samples revealing significant correlations between these markers and clinical parameters, therapy response, and metastasis risks.* -
- Analysis indicated that patients expressing CD24-/CD44+/ALDH1A3+ had higher tumor stages and worse treatment responses, while those with either CD24 or CD44 positivity showed larger tumors and increased nodal burden at younger ages.* -
- The study emphasizes the importance of these CSC markers as predictors of adverse outcomes, suggesting that their presence is associated with higher rates of distant metastasis and reduced effectiveness of chemotherapy in breast cancer patients.*
Enrichment of cancer stem cell subpopulation alters the glycogene expression profile of colorectal cancer cells.
Discov Oncol
November 2024
Cellular and Molecular Oncobiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil.
Article Synopsis
- Colorectal cancer (CRC) has a high mortality rate due to metastasis and disease recurrence, with cancer stem cells (CSCs) playing a key role in these processes and resisting standard treatments.
- The study examined glycobiomarkers in colorectal CSC subpopulations using sphere formation assays on CACO-2 and HT-29 cell lines, revealing changes in the expression of several CSC markers and glycogenes.
- In silico analyses showed that higher expression of certain glycogenes, especially OGA, correlates with poorer survival outcomes for colon and rectum cancer patients, suggesting the importance of OGA in CRC progression.
Cyclophilin A knockdown inhibits the proliferation and metastatic ability of AGS gastric cancer stem cells by downregulating CD147/STAT3/AKT/ERK and epithelial‑mesenchymal transition.
Mol Med Rep
January 2025
Department of Life Science and Biochemical Engineering, Graduate School, Sun Moon University, Asan, Chungcheongnam 31460, Republic of Korea.
Gastric cancer stem cells (GCSCs) contribute to the challenging aspects of gastric cancer, such as progression, metastasis, treatment resistance and recurrence. Inhibitors targeting cyclophilin A (CypA) have shown potential in curtailing GCSC growth. Building upon this, the current study delved deeper into understanding the functional role of CypA in controlling the proliferation and metastatic capabilities of GCSCs, employing CypA‑specific small interfering RNA.
View Article and Find Full Text PDFConcise review: breast cancer stems cells and their role in metastases.
Ann Med Surg (Lond)
September 2024
Department of Laboratory Sciences, School of Allied Medical Sciences, Dezful University of Medical Sciences, Dezful, Iran.
Background: Breast cancer stem cells (BCSCs) have been suggested to be responsible for the development of Breast cancer (BC). The aim of this study was to evaluate BCSCs and the target organs microenvironment immunophenotyping markers in common BC metastases, and therapeutic targets regarding to the mentioned criteria.
Material And Methods: This narrative review involved searching international databases; PubMed, Google Scholar using predetermined keywords including breast cancer, breast cancer stem cells, breast cancer metastases, immunophenotyping, immunohistochemistry and metastases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!